Award
NIH Reporter #1R21CA318124-01
Defining the PARP14 interactome in RIG-I activated colorectal cancers
Recipient
Oregon Health & Science University
Award Amount
$216,822.00
Ceiling
$216,822.00
Awarded
September 01, 2026
Identifier
1R21CA318124-01
NIH grant awarded to Oregon Health & Science University to study the role of PARP14 in enhancing immune response against colorectal cancers activated by RIG-I, with a funding amount of $216,822.
Description
This NIH grant supports research on the role of PARP14 in RIG-I mediated tumor suppression, with potential therapeutic implications. The study aims to define the cross-talk between RIG-I signaling and non-canonical PARP family proteins using chemical biology approaches to identify the direct targets of PARP14 in RIG-I activated tumors.